High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-x(L)-expressing CD34+-proliferating haematopoietic progenitors

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 654-662

  Marone, Maria ^a   Pierelli, Luca ^a   Mozzetti, Simona ^a   Masciullo, Valeria ^b   Bonanno, Giuseppina ^a   Morosetti, Roberta ^a   Rutella, Sergio ^a   Battaglia, Alessandra ^a   Rumi, Carlo ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a   Giordano, Antonio ^b   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bcl 2; Bcl X(L); CD34+; CDKs; Progenitors

Indexed keywords

6 CARBOXYFLUORESCEIN; ACETOACETIC ACID; CD34 ANTIGEN; CELL PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; FLUORESCENT DYE; GRANULOCYTE COLONY STIMULATING FACTOR; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN CDC2; PROTEIN NM 23; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN PU 1; SUCCINIMIDE DERIVATIVE; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

ANTIGENS, CD34; APOPTOSIS; BCL-X PROTEIN; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HEMATOPOIETIC STEM CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0033777115     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02227.x     Document Type: Article

References (42)

1. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver
2. Analysis of gene expression in a complex differentiating hierarchy by global amplification of cDNA from single cells
3. Nm23 gene expression correlates with cell growth rate and S-phase
4. Bcl-2 family: Regulators of cells death
5. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line
6. Fas-induced apoptosis and cdc2 and cdk2 kinase activity are not sufficient for triggering apoptosis in HUT-78 cells
7. + subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets
8. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells
9. Mechanisms and function of cell death
10. p21-Negative regulator of the cell cycle
11. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
12. Suppression of apoptotic cell death by signaling through the IL-3/GM-CSF receptors
13. + hematopoietic progenitor cells residing in G(0)
14. Regulation of Bcl-2, Bcl-xL and Bax in the control of apoptosis by hematopoietic cytokines and dexamethasone
15. Role of p53 and Rb on in vitro growth of normal umbilical cord blood cells
16. Cyclin E and cdk2 alterations in ovarian cancer: Amplification and overexpression
17. Bcl-2, bax, bcl-x(l) and bcl-x(s) expression in normal and neoplastic ovarian tissues
18. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian carcinoma cancer
19. Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rbG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer
20. A novel, myeloid transcription factor, C/EBP, is upregulated during granulocytic, but not monocytic, differentiation
21. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lyn- subpopulation from mobilized peripheral blood
22. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
23. Cytokine regulation of apoptosis in hematopoietic precursors
24. Primitive human hematopoietic precursors express bcl-x but not bcl-2
25. + haematopoietic progenitors
26. c-Myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle
27. + cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens Stem Cells
28. The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage
29. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells
30. Cytokine induction of proliferation and expression of CDC2 and cyclin A in FDC-P1 myeloid hematopoietic progenitor cells: Regulation of ubiquituous and cell cycle-dependent histone gene transcription factors
31. 1 cyclin-dependent kinases
32. Characterization of the human cyclin-dependent kinase 2 gene. Promoter analysis and gene structure
33. Induction of p21 (WAF-1/CIP1) during differentiation
34. Regulation of p21 (WAF1) expression during normal myeloid differentiation
35. In vivo structure of the human cdc2 promoter: Release of a p130-1E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression
36. Evaluation of ex vivo expansion of potential cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis
37. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival
38. Monitoring mRNA expression by polymerase chain reaction by the 'primer dropping' method
39. Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation
40. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells
41. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture
42. P53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation